Dawson James Securities Announces the Closing of Public Offering Unit Transaction for Sigma Labs, Inc.
March 15 2019 - 1:37PM
Dawson James Securities, Inc. in conjunction with Sigma Labs, Inc.
(NASDAQ:SGLB) today announced the closing of the public offering of
1,400,800 units, with each unit consisting of one share of common
stock and 30% of a warrant to purchase one share of common stock,
at a combined price of $1.40 per unit. The warrants are
immediately exercisable at a price of $1.61 per share and will
expire on the fifth anniversary of the date of issuance.
The Company received gross proceeds of
$1,961,120 from this offering and will be used for general working
capital and other corporate purposes.
Dawson James Securities, Inc. acted as the
exclusive placement agent in connection with the offering.
The shares and warrants are being offered
pursuant to an effective shelf registration statement on Form S-3
(File No. 333-225377), that was previously filed with the
Securities and Exchange Commission (SEC) and declared effective on
June 14, 2018. The securities may be offered only by means of a
prospectus. The prospectus and a preliminary prospectus supplement
related to the offering have been filed with the SEC and are
available on the SEC's website located at http://www.sec.gov.
A final prospectus supplement and accompanying prospectus relating
to the offering will be filed with the SEC and will be available on
the SEC's website at www.sec.gov. Copies of the final
prospectus supplement and accompanying prospectus relating to the
offering, when available, may also be obtained by contacting Dawson
James Securities, Inc., Attention: Prospectus Department, 1 North
Federal Highway, 5th Floor, Boca Raton, FL 33432, or by
telephone toll free at 866-928-0928, or by e-mail
at mmaclaren@dawsonjames.com.
About Sigma Labs, Inc.
Sigma Labs, Inc. is a provider of quality
assurance software under the PrintRite3D® brand and a developer of
advanced, in-process, non-destructive quality assurance software
for commercial firms worldwide seeking productive solutions for
advanced manufacturing. For more information please visit us
at www.sigmalabsinc.com.
About Dawson James
Securities
Dawson James Securities specializes in capital
raising for small and microcap public and private growth companies
primarily in the Life Science/Health Care, Technology and Consumer
sectors and is a full-service investment banking firm with
research, institutional as well as retail sales, execution trading
and corporate services. Headquartered in Boca Raton, FL,
Dawson James is privately held with offices in New York, Maryland
and New Jersey. www.dawsonjames.com
Safe Harbor Statement
Safe Harbor Statement under the Private
Securities Litigation Reform Act of 1995: This news release
may contain forward-looking information within the meaning of
Section 27A Of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended, including
statements that include the words “believes”, “expects”,
“anticipates” or similar expressions. Such forward-looking
statements involve known and unknown risks, uncertainties and other
factors that may cause the actual results, performance or
achievements of the Company to differ materially from those
expressed or implied by such forward-looking
statements.
Member FINRA/SIPC. For more
information, please contact:
Elise Stern, Sr. Managing
Directorestern@dawsonjames.com561-208-2926
Sigma Labs (NASDAQ:SGLB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sigma Labs (NASDAQ:SGLB)
Historical Stock Chart
From Sep 2023 to Sep 2024